Cargando…
HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland
Recently, we found that mutation of the C-terminus of transcription factor Hexamethylene bisacetamide inducible protein 1 (HEXIM1) in mice leads to abnormalities in cardiovascular development due to aberrant vascular endothelial growth factor (VEGF) expression. HEXIM1 regulation of some genes has al...
Autores principales: | Ogba, Ndiya, Doughman, Yong Qiu, Chaplin, Laura J., Hu, Yanduan, Gargesha, Madhusudhana, Watanabe, Michiko, Montano, Monica M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892028/ https://www.ncbi.nlm.nih.gov/pubmed/20453883 http://dx.doi.org/10.1038/onc.2010.110 |
Ejemplares similares
-
HEXIM1 is a critical determinant of the response to tamoxifen
por: Ketchart, Wannarasmi, et al.
Publicado: (2011) -
Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis
por: Ketchart, Wannarasmi, et al.
Publicado: (2012) -
Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance
por: Sharma, Vikas, et al.
Publicado: (2020) -
Inhibition of Tat activity by the HEXIM1 protein
por: Fraldi, Alessandro, et al.
Publicado: (2005) -
Bovine mammary epithelial cell cultures for the study of mammary gland functions
por: Jedrzejczak, Magdalena, et al.
Publicado: (2013)